Alois Alzheimer's microscope and childhood home (Eli Lilly)

Fail­ure, faith and $8 bil­lion: How Lil­ly's amy­loid con­vic­tion brought it to the brink of Alzheimer's ap­proval

(This sto­ry was orig­i­nal­ly pub­lished in Feb­ru­ary 2024, and is be­ing re-run fol­low­ing the ap­proval of do­nanemab.)

Twen­ty-nine years ago, Eli Lil­ly bought …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.